These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7481252)

  • 1. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Economic approach to breast cancer screening in Belgium].
    Grivegnée AR; Autier P
    Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic considerations in breast cancer screening of older women.
    Brown ML
    J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Flemish women in semi-rural areas be motivated to attend organized breast cancer screening?
    Van Hal G; Matthyssen M; Thibaut A; Weyler J
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):119-27. PubMed ID: 10367299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of breast cancer in women.
    Humphrey LL; Ballard DJ
    Prim Care; 1989 Mar; 16(1):115-32. PubMed ID: 2495540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
    Spratt JS; Gaines BM; Aaron WS; Cerrito P
    J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
    [No Abstract]   [Full Text] [Related]  

  • 14. Mammographic screening for breast cancer: An invited review of the benefits and costs.
    Greif JM
    Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening under 50: a limited perspective on a multifaceted issue.
    Royak-Schaler R; Gallant SJ; Klabunde CN
    Womens Health; 1996; 2(4):243-9; discussion 261-6. PubMed ID: 9421559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of outreach assessment clinics in breast screening programmes.
    van der Pol MM; Cairns JA; Gilbert FJ; Hendry PJ
    Int J Health Plann Manage; 1999; 14(1):57-67. PubMed ID: 10351680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat bite: Frequency of breast cancer screening by health plan, 2000-2003.
    J Natl Cancer Inst; 2004 Nov; 96(22):1657. PubMed ID: 15547177
    [No Abstract]   [Full Text] [Related]  

  • 19. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.